Single exposure for Musculoskeletal Pain

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Musculoskeletal PainDelayed onset muscle soreness. - Behavioral
Eligibility
18 - 70
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study how people's bodies naturally manage pain, and if this can be improved through training.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Fluoxetine
1
Vitamin D
1
Ergocalciferol (Vitamin D2)

Study Objectives

3 Primary · 1 Secondary · Reporting Duration: Baseline up to 10 weeks

Week 10
Pain
Change in pressure quantitative sensory testing
Change in thermal quantitative sensory testing
Cortical network connectivity

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Fluoxetine
1
Vitamin D
2
Ergocalciferol (Vitamin D2)

Trial Design

3 Treatment Groups

Single exposure
1 of 3
Repeated exposure
1 of 3
Natural history
1 of 3

Active Control

180 Total Participants · 3 Treatment Groups

Primary Treatment: Single exposure · No Placebo Group · N/A

Single exposure
Behavioral
ActiveComparator Group · 1 Intervention: Delayed onset muscle soreness. · Intervention Types: Behavioral
Repeated exposure
Behavioral
ActiveComparator Group · 1 Intervention: Delayed onset muscle soreness. · Intervention Types: Behavioral
Natural historyNoIntervention Group · 1 Intervention: Natural history · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline up to 10 weeks

Who is running the clinical trial?

University of FloridaLead Sponsor
1,250 Previous Clinical Trials
698,573 Total Patients Enrolled
6 Trials studying Musculoskeletal Pain
1,390 Patients Enrolled for Musculoskeletal Pain
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
447 Previous Clinical Trials
1,072,280 Total Patients Enrolled
1 Trials studying Musculoskeletal Pain
70 Patients Enrolled for Musculoskeletal Pain
Michael E Robinson, PhDPrincipal InvestigatorUniversity of Florida
1 Previous Clinical Trials
50 Total Patients Enrolled

Eligibility Criteria

Age 18 - 70 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Participants with WMP must meet the ACR (2010) diagnostic criteria of multiple regions of muscle pain.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top